Response to Ruggles and Cheung, Re: "Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study"

针对 Ruggles 和 Cheung 的回复：“对于未经治疗的跨性别女性的性别肯定激素治疗，舌下含服雌二醇与口服雌二醇和醋酸环丙孕酮联合用药并无明显优势：一项前瞻性试点研究的结果”